Completeomics
Founded 2019 · 14 employees on LinkedIn · 1 known investors
Find your way into Completeomics
Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics. The platform guides the design of targeted treatments such as mRNA vaccines and cell therapies.
Founders & leadership
Completeomics was founded in 2019 by Ming Zhang.
MZ
Ming ZhangCo-Founder and Chief Intellectual Property Officer
Investors · 1
Frequently asked questions
- What does Completeomics do?
- Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics. The platform guides the design of targeted treatments such as mRNA vaccines and cell therapies.
- Who founded Completeomics?
- Completeomics was founded by Ming Zhang in 2019.
- Who are Completeomics's investors?
- Completeomics's investors include Qiming Venture Partners.